Brief: Day One Provides Updated Firefly-1 Data For Tovorafenib

Day One Biopharmaceuticals

11/09/2023 15:37

Sept 11 (Reuters) - Day One Biopharmaceuticals Inc
 DAWN.O :
    * DAY ONE ANNOUNCES UPDATED FIREFLY-1 DATA FOR TOVORAFENIB
AND
COMPLETION OF ROLLING NDA SUBMISSION TO FDA FOR RELAPSED OR
PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG)
    * DAY ONE BIOPHARMACEUTICALS INC - ANTICIPATES FDA WILL FILE
ROLLING NDA BY MID-NOVEMBER 2023

Source text for Eikon:  ID:nGNXb03992 
Further company coverage:  DAWN.O 

 ((reuters.briefs@thomsonreuters.com;))